Results 121 to 130 of about 2,347,326 (232)

Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study [PDF]

, 2017
Background: Relapsed or refractory diffuse large B-cell and mantle-cell lymphoma have a poor prognosis. The EPOCH regimen and rituximab monotherapy have demonstrated activity as salvage therapies.
Betticher, D. C., Egli, F., Honegger, H. P., Jacky, E., Jermann, M., Jost, L. M., Kroner, Th, Stahel, R. A., Taverna, Ch   +8 more
core  

Characterization and comparison of two newly established epstein‐barr virus‐negative lymphoma B‐cell lines: Surface markers, growth characteristics, cytogenetics, and transplantability

Cancer, 1988
M. Abe, Y. Nozawa, H. Wakasa, H. Ohno, S. Fukuhara   +4 more
semanticscholar   +1 more source

Lymphoma stem cells: enough evidence to support their existence? [PDF]

, 2010
While leukemia-originating stem cells are critical in the initiation and maintenance of leukemias, the existence of similar cell populations that may generate B-cell lymphoma upon mutation remains uncertain.
Fontan, L. (Lorena), Gascoyne, R.D (R. D.), Martinez-Climent, J.A. (José Ángel), Prosper, F. (Felipe), Siebert, R. (Reiner)   +4 more
core  

Self-antigen recognition by follicular lymphoma B-cell receptors.

Blood, 2012
K. Sachen, M. Strohman, J. Singletary, Ash A. Alizadeh, Nicole H. Kattah, Chen Lossos, E. Mellins, S. Levy, R. Levy   +8 more
semanticscholar   +1 more source

Associations between gut microbiota and immune status in untreated B-cell lymphoma patients

Frontiers in Immunology
BackgroundEmerging evidence links gut microbiota to tumorigenesis via immune modulation, though subtype-specific microbial signatures in B-cell lymphomas remain unclear.
Jingxin Zhou, Jingxin Zhou, Jinrong Yao, Na Hu, Jing Su   +4 more
doaj   +1 more source

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Blood, 2004
C. Hans, D. Weisenburger, T. Greiner, R. Gascoyne, J. Delabie, G. Ott, H. Müller-hermelink, E. Campo, R. Braziel, E. Jaffe, Zenggang Pan, Pedro Farinha, Lynette M. Smith, B. Falini, A. Banham, A. Rosenwald, L. Staudt, J. Connors, J. Armitage, W. Chan   +19 more
semanticscholar   +1 more source

Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas

Frontiers in Oncology
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach in the treatment of lymphoma. This review article provides an overview of the four FDA-approved CAR T-cell products for aggressive B-cell lymphoma, including diffuse large B-cell ...
Bei Hu, Victoria Korsos, M. Lia Palomba, M. Lia Palomba   +3 more
doaj   +1 more source

Prevalence profile of cutaneous T- and B-cell lymphoma in Gharbia Governorate, Egypt

Journal of the Egyptian Women’s Dermatologic Society
Background Lymphomas represent a heterogeneous group of lymphoid malignancies with varied patterns of clinical behavior and responses to treatment. The WHO classification distinguishes lymphoid neoplasms derived from precursor lymphoid cells from those ...
Nagwa M. Elwan, Dina A. Badawy, Salwa A. Atlam, Ghada F. R. Hassan   +3 more
doaj   +1 more source

Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma

New England Journal of Medicine, 2018
R. Schmitz, George W. Wright, D. Huang, Calvin A. Johnson, J. Phelan, James Q Wang, S. Roulland, M. Kasbekar, R. Young, A. Shaffer, D. Hodson, Wenming Xiao, Xin Yu, Yandan Yang, Hong Zhao, Weihong Xu, Xuelu Liu, Bin Zhou, Wei Du, W. Chan, E. Jaffe, R. Gascoyne, J. Connors, E. Campo, A. López-Guillermo, A. Rosenwald, G. Ott, J. Delabie, L. Rimsza, Kevin Tay Kuang Wei, A. Zelenetz, J. Leonard, N. Bartlett, Bao Tran, Jyoti Shetty, Yongmei Zhao, D. Soppet, S. Pittaluga, W. Wilson, L. Staudt   +39 more
semanticscholar   +1 more source

Adhesion molecule profiles of B-cell non-Hodgkin's lymphomas in the leukemic phase

Brazilian Journal of Medical and Biological Research, 2006
We evaluated the expression of 10 adhesion molecules on peripheral blood tumor cells of 17 patients with chronic lymphocytic leukemia, 17 with mantle-cell lymphoma, and 13 with nodal or splenic marginal B-cell lymphoma, all in the leukemic phase and ...
D.M. Matos, E.G. Rizzatti, A.B. Garcia, D.A.P. Gallo, R.P. Falcão   +4 more
doaj